the sympatico trial: ibrutinib plus venetoclax in tp53-mutated mcl
Published 4 months ago • 229 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
3:18
sympatico: safety and efficacy of ibrutinib plus venetoclax for r/r mcl
-
1:36
cll2-give trial: ibrutinib, venetoclax and obinutuzumab in patients with tp53-mutated cll
-
1:52
sympatico: primary analysis results of ibrutinib plus venetoclax for patients with r/r mcl
-
1:21
ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed mcl
-
1:30
oasis trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed mcl
-
2:00
preliminary results of the aim trial of ibrutinib and venetoclax in mantle cell lymphoma
-
1:30
final results of the aim study of ibrutinib and venetoclax in mantle cell lymphoma
-
1:05
final analysis of the alpine trial: zanubrutinib vs ibrutinib in r/r cll
-
42:48
2021-03-28 啟示錄(29) 白色大寶座:終極審判(启示录20:11-15)
-
53:53
mantle cell lymphoma case
-
1:55
pancreatic spen tumor
-
0:49
overview of the cll2-big trial of ibrutinib and obinutuzumab
-
2:45
optimizing the combination of ibrutinib plus venetoclax in cll
-
3:27
venetoclax: an unmet need in r/r mantle cell lymphoma after btk inhibitors
-
2:08
the venice-1 trial: venetoclax monotherapy in r/r cll
-
5:29
helios trial: ibrutinib combined with br for previously treated cll/sll
-
4:01
ibrutinib vs temsirolimus in relapsed/refractory mantle cell lymphoma
-
1:32
novel btki strategies in indolent b-cell malignancies: pirtobrutinib for fl and mzl
-
1:43
extended follow-up of the alpine trial: superior outcomes with zanubrutinib in r/r cll/sll
-
2:07
novel treatments for mantle cell lymphoma
-
2:39
overview of the lumiere clinical trial in peripheral t-cell lymphoma
-
2:31
relevance trial analysis: investigating the impact of lymphocyte/monocyte ratio on patient outcomes